Ontazolast

CAS No. 147432-77-7

Ontazolast( —— )

Catalog No. M36207 CAS No. 147432-77-7

Ontazolast is a small molecule leukotriene B4 receptor (LTB4R) antagonist for the treatment of immune system disorders and respiratory diseases.Ontazolast is a candidate compound for the treatment of asthma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 129 Get Quote
5MG 200 Get Quote
10MG 295 Get Quote
25MG 539 Get Quote
50MG 718 Get Quote
100MG 981 Get Quote
500MG 1962 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ontazolast
  • Note
    Research use only, not for human use.
  • Brief Description
    Ontazolast is a small molecule leukotriene B4 receptor (LTB4R) antagonist for the treatment of immune system disorders and respiratory diseases.Ontazolast is a candidate compound for the treatment of asthma.
  • Description
    Ontazolast is a small molecule leukotriene B4 receptor (LTB4R) antagonist for the treatment of immune system disorders and respiratory diseases.Ontazolast is a candidate compound for the treatment of asthma.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    LTR
  • Recptor
    LTR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    147432-77-7
  • Formula Weight
    335.44
  • Molecular Formula
    C21H25N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N([C@@H](CC1CCCCC1)C2=CC=CC=N2)C=3OC=4C(N3)=CC(C)=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CP-105696

    CP-105696 is a potent and selective leukotriene B4 (LTB4) receptor antagonist used to study allograft rejection.

  • MK 571

    MK 571 is an orally active antagonist of CysLT1 receptor .

  • Tebufelone

    Tebufelone is a potent in vitro inhibitor of CO , a novel non-steroidal anti-inflammatory drug (NSAID) belonging to the di-tert-butylphenol (DTBP) class that has shown potent anti-inflammatory, analgesic and anti-reticulitis properties in various animal models.